Roche’s Investor Event at ASCO 2026
Roche has hosted an Investor Event at ASCO on Tuesday, 2 June 2026.
| Agenda | |
|---|---|
| Introduction | Bruno Eschli, Head of Investor Relations |
| Roche oncology strategy and portfolio highlights | Wendy Cheung, Therapeutic Area Head Oncology & Hematology, Global Product Strategy |
| Breast cancer franchise update | Aakanksha Khandelwal, Disease Area Head Breast, Global Product Strategy |
| Giredestrant Ph III study results in breast cancer: evERA, persevERA, lidERA | Aditya Bardia, MD, MPH, FASCO, Professor of Medicine, Geffen School of Medicine, University of California Los Angeles |
| Q&A |
Webinar Replay
Please click the video below to watch the replay of the webinar.